Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Stille

184.50 SEK

+5.13 %

Less than 1K followers

STIL

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+5.13 %
+6.65 %
-5.87 %
+5.73 %
-16.52 %
-26.79 %
+59.05 %
+109.66 %
+78.00 %

Stille develops, manufactures and markets medical devices for specialist surgeons. Priority areas are surgical instruments and special tables for cardiovascular surgery, gynecology and urology. The company's products are used by users on a global level. In addition to its core business, it also offers instrument care training. Stille was originally founded in 1841 and has its headquarters in Eskilstuna.

Read more
Market cap
1.66B SEK
Turnover
3.01M SEK
Revenue
567.63M
EBIT %
12.9 %
P/E
29.76
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
24/4
2026

Interim report Q1'26

23/7
2026

Interim report Q2'26

23/10
2026

Interim report Q3'26

All
Press releases
ShowingAll content types
Press release2/13/2026, 12:04 PM

Redeye: Stille: (Q4 review): Easing headwinds and solid outlook at 11x current year EV/EBITDA

Stille
Regulatory press release2/12/2026, 7:00 AM

Stille AB (publ) today presents the report for the fourth quarter and full year 2025.

Stille
Regulatory press release2/12/2026, 7:00 AM

Stille AB (publ) redovisar idag rapporten för det fjärde kvartalet och helåret 2025.

Stille

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release12/23/2025, 1:40 PM

Rättelse: Valberedning för årsstämman 2026 i Stille

Stille
Regulatory press release12/23/2025, 1:40 PM

Correction: Nominating Committee for the Annual General Meeting 2026 in Stille

Stille
Regulatory press release12/23/2025, 1:00 PM

Valberedning för årsstämmman 2026 i Stille

Stille
Regulatory press release12/23/2025, 1:00 PM

Nominating Committee for the Annual General Meeting 2026 in Stille

Stille
Press release10/27/2025, 1:31 PM

Redeye: Stille (Q3 update) - Prolonged headwind but valuation remains undemanding

Stille
Regulatory press release10/23/2025, 6:00 AM

Stille AB (publ) redovisar idag rapporten för det tredje kvartalet 2025.

Stille
Regulatory press release10/23/2025, 6:00 AM

Stille AB (publ) today presents the report for the third quarter 2025.

Stille
Regulatory press release10/15/2025, 6:00 AM

Stille AB offentliggör ny koncernledning och organisationsstruktur

Stille
Regulatory press release10/15/2025, 6:00 AM

Stille AB announces new Executive Management and group structure

Stille
Regulatory press release9/18/2025, 2:00 PM

Johan Lundholm lämnar sin tjänst som ”Affärsområdeschef – Operationsbord” inom Stille

Stille
Regulatory press release9/18/2025, 2:00 PM

Johan Lundholm to leave his Position as “Business Unit Manager – Surgical Tables” of Stille

Stille
Regulatory press release8/1/2025, 12:00 PM

Stille slutför förvärvet av Surgical Holdings

Stille
Regulatory press release8/1/2025, 12:00 PM

Stille completes the acquisition of Surgical Holdings

Stille
Press release7/21/2025, 6:21 AM

Redeye: Stille Q2 2025 - Temporary weakness, expected rebound in H2

Stille
Regulatory press release7/17/2025, 6:00 AM

Stille AB: Delårsrapport Q2 2025

Stille
Regulatory press release7/17/2025, 6:00 AM

Stille AB: Interim Report Q2 2025

Stille
Regulatory press release7/2/2025, 4:15 PM

Stille har tecknat avtal om att förvärva Surgical Holdings

Stille
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.